Share on Facebook Share on Twitter Email
Answers.com

Menkes disease

 
Medical Dictionary: kink·y-hair disease
(kĭng'kē-hâr')
n.

A congenital metabolic defect manifested by short, sparse, poorly pigmented kinky hair and associated with failure to thrive, physical and mental retardation, and progressive deterioration of the brain. Also called Menkes syndrome.

Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
Wikipedia: Menkes disease
Top
Menkes disease
Classification and external resources

ATP7A
ICD-10 E83.0
ICD-9 759.89
OMIM 309400
DiseasesDB 8029
eMedicine neuro/569 ped/1417 derm/715
MeSH D007706

Menkes disease (also called the kinky hair disease or Menkes kinky hair syndrome[1]:765) is a disorder that affects copper levels in the body,[2] leading to copper deficiency.[3]

It was originally described by Menkes et al. in 1962.[4]

It is an x-linked recessive disorder, and is therefore considerably more common in males: females require two defective alleles to develop the disease.

Contents

Presentation

It is characterized by sparse and coarse hair, growth failure, and deterioration of the nervous system. Onset of Menkes syndrome typically begins during infancy. Signs and symptoms of this disorder include weak muscle tone (hypotonia), sagging facial features, seizures, mental retardation, and developmental delay. The patients have brittle hair and metaphyseal widening. In rare cases, symptoms begin later in childhood and are less severe.

Occipital horn syndrome (sometimes called X-linked cutis laxa or Ehlers-Danlos type 9[5]), is a mild form of Menkes syndrome that begins in early to middle childhood. It is characterized by calcium deposits in a bone at the base of the skull (occipital bone), coarse hair, and loose skin and joints.

Epidemiology

One European study reported a rate of 1 in 254,000;[6] a Japanese study reported a rate of 1 in 357,143.[7]

Symptoms

Microscopic examination of hair, revealing classical sign of pili torti. From Datta et al., 2008.

Affected infants may be born prematurely. Symptoms appear during infancy and are largely a result of abnormal intestinal copper absorption with secondary deficiency in copper-dependent mitochondrial enzymes. Normal or slightly slowed development may proceed for 2 to 3 months, and then there will be severe developmental delay and a loss of early developmental skills. Menkes Disease is also characterized by seizures, failure to thrive, subnormal body temperature, and strikingly peculiar hair, which is kinky, colorless or steel-colored, and easily broken. There can be extensive neurodegeneration in the gray matter of the brain.[8] Arteries in the brain can also be twisted with frayed and split inner walls. This can lead to rupture or blockage of the arteries. Weakened bones (osteoporosis) may result in fractures.

Urine homovanillic acid/vanillylmandelic acid ratio has been proposed as a screening tool to support earlier detection.[9]

Treatment

Early treatment with subcutaneous (under the skin) or intravenous (in a vein) injections of copper supplements (in the form of acetate salts) may be of some benefit.[10]

Other treatment is symptomatic and supportive.

Genetics

Mutations in the ATP7A gene cause Menkes syndrome.[11] As the result of a mutation in the ATP7A gene, copper is poorly distributed to cells in the body. Copper accumulates in some tissues, such as the small intestine and kidneys, while the brain and other tissues have unusually low levels. The decreased supply of copper can reduce the activity of numerous copper-containing enzymes that are necessary for the structure and function of bone, skin, hair, blood vessels and the nervous system.

This condition is inherited in an X-linked recessive pattern.[12]

References

  1. ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
  2. ^ Menkes syndrome at Dorland's Medical Dictionary
  3. ^ de Bie P, Muller P, Wijmenga C, Klomp LW (November 2007). "Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes". J. Med. Genet. 44 (11): 673–88. doi:10.1136/jmg.2007.052746. PMID 17717039. http://jmg.bmj.com/cgi/pmidlookup?view=long&pmid=17717039. 
  4. ^ Menkes JH, Alter M, Steigleder GK, Weakley DR, Sung JH (1962). "A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration". Pediatrics 29: 764–79. PMID 14472668. 
  5. ^ http://emedicine.medscape.com/article/1180460-overview
  6. ^ Tønnesen T, Kleijer WJ, Horn N (February 1991). "Incidence of Menkes disease". Hum. Genet. 86 (4): 408–10. doi:10.1007/BF00201846. PMID 1999344. 
  7. ^ Gu YH, Kodama H, Shiga K, Nakata S, Yanagawa Y, Ozawa H (2005). "A survey of Japanese patients with Menkes disease from 1990 to 2003: incidence and early signs before typical symptomatic onset, pointing the way to earlier diagnosis". J. Inherit. Metab. Dis. 28 (4): 473–8. doi:10.1007/s10545-005-0473-3. PMID 15902550. 
  8. ^ Barnes N, Tsivkovskii R, Tsivkovskaia N, Lutsenko S (2005). "The copper-transporting ATPases, menkes and wilson disease proteins, have distinct roles in adult and developing cerebellum". J Biol Chem 280 (10): 9640–5. doi:10.1074/jbc.M413840200. PMID 15634671. 
  9. ^ Matsuo M, Tasaki R, Kodama H, Hamasaki Y (2005). "Screening for Menkes disease using the urine HVA/VMA ratio". J. Inherit. Metab. Dis. 28 (1): 89–93. doi:10.1007/s10545-005-5083-6. PMID 15702409. 
  10. ^ Kaler SG, Holmes CS, Goldstein DS, et al. (February 2008). "Neonatal diagnosis and treatment of Menkes disease". N. Engl. J. Med. 358 (6): 605–14. doi:10.1056/NEJMoa070613. PMID 18256395. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=18256395&promo=ONFLNS19. 
  11. ^ Voskoboinik I, Camakaris J (2002). "Menkes copper-translocating P-type ATPase (ATP7A): biochemical and cell biology properties, and role in Menkes disease". J Bioenerg Biomembr 34 (5): 363–71. doi:10.1023/A:1021250003104. PMID 12539963. 
  12. ^ Kim BE, Smith K, Meagher CK, Petris MJ (November 2002). "A conditional mutation affecting localization of the Menkes disease copper ATPase. Suppression by copper supplementation". J. Biol. Chem. 277 (46): 44079–84. doi:10.1074/jbc.M208737200. PMID 12221109. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=12221109. 

External links


 
 

 

Copyrights:

Medical Dictionary. The American Heritage® Stedman's Medical Dictionary Copyright © 2002, 2001, 1995 by Houghton Mifflin Company Read more
Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Menkes disease" Read more